Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Mergers and Acquisitions

Project details

Cambridge based biotech R&D firm with unparalleled track record looking for investors

Project region Britain
Industry Healthcare
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365

CONTACT ADVISOR

Simon Laube
Assistant Manager, International Business Advisory
Project highlights To be confirmed
Project description

The company is a Cambridge based biotechnology contract research and drug development company, which operates a mixed business model. The revenue is generated through its service business and the development of drug products. The company has an excellent track record in candidate drug delivery. It has a world-class discovery team, and its unparalleled track record shows that it has delivered one candidate drug on behalf of its customers every year in the past six years. Revenue in 2019 was approximately £ 6 million, of which 83% of sales came from a strong growing industrial customer base, which has now become the core of the business.

Get in touch

We provide expert advisory and corporate services across Asia, guiding businesses through complex markets and regulations.

Have Any Questions?

Reach out to our local experts, we’ll respond within one business day.

captcha image

Our Clients

Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.

See what our clients say about us

It appears that you have recently submitted an inquiry on this topic. Would you like to
replace your previous submission with this one?